Dr. Reddy's Recalls Prescription Drug Blister Packages Due to Risk of Poisoning

Recall Insight

This CPSC action (record #21089) was formally reported on February 25, 2021. It is classified under Moderate severity, with a current status of Active. Dr. Reddy's Laboratories, Ltd., of India is listed as the recalling firm. Federal records indicate About 21,400 units are affected.

The documented reason for this recall is: The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and co… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund. — consumers holding this product should act on that instruction rather than relying on general guidance.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 1 were also issued by CPSC. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 5 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.